# FDA Inspection 1261897 - Bayer Hispania, S.L. - June 17, 2022

Source: https://www.keypedia.com/records/fda_inspections/bayer-hispania-sl/d93cd4c2-3a27-4343-a8b8-6a91ac61ba63
Source feed: FDA_Inspections

> FDA Inspection 1261897 for Bayer Hispania, S.L. on June 17, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1261897
- Company Name: Bayer Hispania, S.L.
- Inspection Date: 2022-06-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1309214 - 2025-04-24](https://www.keypedia.com/records/fda_inspections/bayer-hispania-sl/ef74d27b-e73b-433e-92a1-8abcea8fb1d4)
- [FDA Inspection 1309214 - 2025-04-24](https://www.keypedia.com/records/fda_inspections/bayer-hispania-sl/bb4984cf-4f93-42ff-91fe-fbc5ba75d4de)
- [FDA Inspection 1261897 - 2022-06-17](https://www.keypedia.com/records/fda_inspections/bayer-hispania-sl/c8709411-503f-4fe6-bdd5-b9a87bc0115c)
- [FDA Inspection 1133477 - 2019-07-09](https://www.keypedia.com/records/fda_inspections/bayer-hispania-sl/39635f48-7c6f-427f-9a7e-071221af915d)
- [FDA Inspection 977576 - 2016-06-17](https://www.keypedia.com/records/fda_inspections/bayer-hispania-sl/b5b52e42-0498-4ce7-93a1-8103c8397576)

Company: https://www.keypedia.com/companies/bayer-hispania-sl/deebd316-d0c0-44b8-90d2-07b9898b5597

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c